Linex Baby powder for oral suspension 1.5 g. sackets №20

Description

Linex Baby powder composition
active substance: Bifidobacterium animalis subsp. lactis;
1 package (1.5 g) of powder for oral suspension contains 1 000 000 000 CFU Bifidobacterium animalis subsp. lactis;
excipient: maltodextrin.

Dosage form
Powder for oral suspension.

Pharmacological properties
Linex Baby powder contains Bifidobacterium animalis subsp. lactis, which is part of the normal intestinal microbiota and belongs to the class of lactic acid bacteria. The microflora of breastfed infants mainly consists of these bacteria, which are considered important in the early period of infant development.
There are several potential mechanisms by which the protective and therapeutic effect of Bifidobacterium animalis subsp. lactis.
Inhibition of growth of pathogenic bacteria occurs by:

• lowering the pH level in the intestinal tract (which is the result of the ability of Bifidobacterium animalis subsp. lactis to produce acids);
• production of metabolites toxic to pathogenic bacteria (production of H2O2);
• production of antibacterial substances, bacteria;
• competition with pathogenic bacteria for nutrients;
• blocking adhesive receptors and thus inhibiting the colonization of other potentially pathogenic microorganisms.

This tool also has a stimulating effect on the immune system.
Impaired intestinal microflora (eg, viral or gastrointestinal infections (including rotavirus infections), treatment with broad-spectrum antibiotics and chemotherapy drugs) or delayed formation of permanent intestinal microflora in infants may induce digestive systems (such as colic, flatulence, diarrhea and constipation) and atopic dermatitis.
Regular intake of Bifidobacterium animalis subsp. lactis effectively reduces the frequency and severity of mild or moderate symptoms of digestive disorders (mainly diarrhea) associated with disruption of the normal intestinal microflora, and ensures regular bowel function.
This drug can also be used to prevent atopic dermatitis and as a supportive agent to stabilize the function of the intestinal immune system.

Indication
Infants from birth and children under 12 years:

• to stabilize and maintain the balance and function of the intestinal microflora;
• as a prophylactic and supportive agent in case of diarrhea, flatulence and other disorders caused by:
  viral and bacterial infections of the gastrointestinal tract (eg rotavirus infections),
• treatment with antimicrobial drugs (antibiotics and other synthetic antimicrobials).

Contraindication
Hypersensitivity to the active substance or to maltodextrin.

Children
Linex Baby powder is used for infants and children under 12 years of age.

Use during pregnancy or breastfeeding
On side effects caused by the use of Bifidobacterium animalis subsp. lactis during pregnancy and lactation, has not been reported. However, in the case of acute diarrhea during pregnancy and lactation, precautions should be taken to prevent fluid and electrolyte deficiency or any other adverse effects that may threaten the unborn child or mother.
Treatment of diarrhea during pregnancy and lactation should be carried out under the supervision of a physician.

Method of application and dosage

• Infants from birth and children under 2 years
  One packet once a day with meals.
• Children aged 2 to 12 years
  One packet once or twice a day with meals.

The package should be opened, pour its contents into a glass of water, juice, milk or baby food.
Linex Baby powder should not be taken with hot drinks.
Linex Baby powder can be taken as long as the appropriate symptoms are present.

Overdose
No cases of overdose have been reported.

Side effects
From the immune system: hypersensitivity reactions (rash, itching).

Expiration date
2 years.

Storage conditions
Store in the original package. Store at a temperature not exceeding 25 ºC. Keep out of reach of children.